The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- ChemAxon Appoints Ferenc Csizmadia as New CEO (2015-04-08)
ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research today announced the appointment of Ferenc Csizmadia as Chief Executive Officer. Previously Ferenc, who is also founder of ChemAxon, has been Chairman of t...
- Roche: EU Approves Avastin plus Chemo for Cervical Cancer (2015-04-08)
Avastin is the first treatment in nearly a decade to extend the life of women with this advanced disease Roche (SIX: RO, ROG, OTCQX, RHHBY) announced today that the European Commission (EU) approved Avastin (bevacizumab) in combination with standard chemothera...
- Maschmeyer Sells His Remaining 1m Shares in Biofrontera (2015-04-08)
Biofrontera AG (AIM/FSE: B8F), the biopharmaceutical company focusing on skin cancer, has stabilized its shareholder structure through an off market block trade of shares. Following intensive selling over the stock markets, the one million remaining shares owned by...
- Nabriva Announces Initial $50m Tranche of $120m Series B (2015-04-07)
> Series B financing includes new investors Vivo Capital and OrbiMed > Lead product lefamulin advancing to Phase 3 Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious...
- Ability Pharmaceuticals: EU Orphan Drug Status for ABTL0812 (2015-04-07)
Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, today announced that the Committee for Orphan Drug Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for orphan drug...
- Bruker: FDA Clears Additional Claim for MALDI Biotyper CA (2015-04-03)
Bruker (NASDAQ: BRKR) today announced that it has received 510(k) clearance from the US Food and Drug Administration for library and methods expansion for the MALDI Biotyper CA System, sold in the United States for clinical microbiology. In November 2013, Bruker...
- GSK to Establish 1 of 3 Global Vaccines R&D Centres in USA (2015-04-02)
GSK announced today it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre for vaccines research and development (R&D) in Rockville, Maryland. The site will become one of three global vaccines R&D centres for ...
- Basilea In-licenses panRAF Kinase Inhibitors (2015-04-01)
Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that it has entered into a license agreement for novel panRAF kinase inhibitors with a consortium of organizations including The Institute of Cancer Research, London, Cancer Research Technology, the Wellcome Trus...
- Dr Susanne Danhauser-Riedl Joins 4SC as CMO from GSK (2015-04-01)
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, today announced the appointment of Dr Susanne Danhauser-Riedl as the Company's Chief Medical Officer (CMO). Dr Danhause...
- Merck Serono Acquires Rights to Malaria Drug from MMV (2015-04-01)
> Worldwide agreement for the investigational antimalarial drug candidate, DDD107498, allows Merck Serono to continue focusing on developing therapies for neglected tropical and poverty-related diseases > Agreement cements collaboration between Merck Serono and ...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSe] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)